ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,965.20
0.36%
Dow Jones
39,344.79
-0.08%
Brent Oil
84.985
-0.50%
Bitcoin
57,602.58
1.58%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Eurobio Scientific (ALERS) Quote

Eurobio Scientific

Eurobio Scientific (ALERS)

EU
14.08
-0.02
( -0.14% )
Updated: 04:35:08
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
14.08
Bid
13.94
Ask
14.08
Volume
559
14.00 Day's Range 14.08
12.20 52 Week Range 18.10
Market Cap
144.509M
Previous Close
14.10
Open
14.00
Last Trade
200
@
14.08
Last Trade Time
03:58:55
Financial Volume
-
VWAP
-
Average Volume (3m)
4,157
Shares Outstanding
10,248,871
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Eurobio Scientific

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eurobio-scientific.com
Headquarters
Les Ulis, Essonne, Fra
Founded
1970
Eurobio Scientific is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALERS. The last closing price for Eurobio Scientific was 14.10 €. Over the last year, Eurobio Scientific shares have traded in a share price range of 12.20 € to 18.10 €.

Eurobio Scientific currently has 10,248,871 shares outstanding. The market capitalization of Eurobio Scientific is 144.51 € million.

ALERS Latest News

More News

Eurobio Scientific : bilan semestriel du contrat de liquidité

Eurobio Scientific : bilan semestriel du contrat de liquidité BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE Paris, le 3 juillet 2024 –17h45 Au titre du contrat de liquidité portant sur les...

July 03 2024
GlobeNewswire Inc.

EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®

EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT® EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER...

May 07 2024
GlobeNewswire Inc.

Eurobio Scientific : mise à disposition du rapport financier annuel 2023

Eurobio Scientific : mise à disposition du rapport financier annuel 2023 MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 Paris, le 26 avril 2024 – 17h45 Eurobio Scientific...

April 26 2024
GlobeNewswire Inc.

Eurobio Scientific : Rapport Financier Annuel 2023

Eurobio Scientific : Rapport Financier Annuel 2023 Eurobio Scientific : Rapport Financier Annuel 2023 Pièce jointe EBS_RFA_2023

April 26 2024
GlobeNewswire Inc.

EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023

EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023 RESULTAT ANNUEL 2023 Croissance du cœur d’activité et déploiement stratégique Chiffre d’affaires Cœur d’activité1 en croissance de 39% à 130 M€ les...

April 10 2024
GlobeNewswire Inc.

Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP

Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP Continued total year growth in core business revenues, up...

January 30 2024
GlobeNewswire Inc.

Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE

Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE Paris, le 17 janvier 2024 – 17h45 Au titre du contrat de liquidité portant sur...

January 17 2024
GlobeNewswire Inc.

Eurobio Scientific : réduction de capital par annulation d’actions auto-détenues

Eurobio Scientific : réduction de capital par annulation d’actions auto-détenues Réduction de capital par annulation d’actions auto-détenues Annulation de 694 300 actions auto-détenues, soit...

January 10 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.282.0289855072513.814.313.8591113.94614224DE
4-0.9-6.0080106809114.9814.9813.8496314.23354328DE
12-1.02-6.7549668874215.115.3813.8415714.53222806DE
26-1.94-12.109862671716.0218.113.8507315.72892309DE
52-0.16-1.1235955056214.2418.112.2555815.53769703DE
156-6.96-33.079847908721.0429.7612.22355219.85519547DE
26010.87338.6292834893.2157.43.085942314.06801008DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PEGYPineapple Energy Inc
$ 2.18
(81.67%)
5.34M
ZAPPZapp Electric Vehicles Group Ltd
$ 13.90
(50.43%)
996.88k
NUWENewellis Inc
$ 4.69
(17.84%)
4.58k
MYNZMainz BioMed NV
$ 0.5591
(17.21%)
4.31M
SVMHSRIVARU Holding Ltd
$ 0.2214
(16.53%)
1.58M
INDVIndivior PLC
$ 8.81
(-42.57%)
29.68k
SHPWShapeways Holdings Inc
$ 0.3759
(-22.91%)
143.69k
GNLNGreenlane Holdings Inc
$ 0.2323
(-19.67%)
1.29M
TXMDTherapeuticsMD Inc
$ 1.38
(-18.84%)
24
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.5996
(-15.83%)
36.67k
PEGYPineapple Energy Inc
$ 2.18
(81.67%)
5.34M
MYNZMainz BioMed NV
$ 0.5591
(17.21%)
4.31M
MAXNMaxeon Solar Technologies Ltd
$ 0.2731
(1.15%)
3.57M
SVMHSRIVARU Holding Ltd
$ 0.2214
(16.53%)
1.58M
GNLNGreenlane Holdings Inc
$ 0.2323
(-19.67%)
1.29M

Discussion

View Full Feed
Hummingbird2 Hummingbird2 3 minutes ago
https://x.com/kshaughnessy2/status/1810598516298805307

$GTII
GTII
Big Brother Big Brother 6 minutes ago
That was dilution, BBAR was the MM who was diluting and on top of the ASK. That's a newer MPID for them I believe, I saw them the other day on a ticker and didn't recognize them, however, now I know its Buckman, Buckman & Reid, Inc the old MPID was BKRT. BKRT was a notorious diluter, much like VNDM,
TONR
dennisdave dennisdave 8 minutes ago
Powers said that the reason they have submitted with the MHRa first is because the MHRA is the fastest in their review process.
Now that we found out that most likely the MHRA approval process will take until the end of the year, aka one year in total, we can conclude that is the same timeli
NWBO
meshcan meshcan 11 minutes ago
Thanks, I probably put a buy for 150,000 additional shares @ 0.165 ish

Cheers
ELTP
CarlCarlMcB CarlCarlMcB 11 minutes ago
Harpoon $$$$$$ whale on $$$$$$ reeling $$$$$
AMRN
jbog jbog 11 minutes ago
Comparison between Lilly and Nova

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080?guestAccessKey=1d98a3bc-0a11-444c-a21a-2b875588f3f0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824
Nemesis18 Nemesis18 13 minutes ago
Simply follow the money, the terms of the commercial partnership agreement with Kings Health Partnership, and the ongoing incentives in place, that came as a direct result of a positive trial outcome.
Kings do not have clean hands.
This Trust, at any time, can take legal action against
NWBO
jay14 jay14 17 minutes ago
That's a 30 year question which
seems like it will never be answered....lol
TMMI
edminnema edminnema 18 minutes ago
Yup, was rectified, phew, was starting to think another 12 years
GOGR
knrorrel knrorrel 19 minutes ago
great
RSPI
knrorrel knrorrel 20 minutes ago
awesome
RSPI
Dyno89 Dyno89 25 minutes ago
Perfect example why they will never allow this to sit in EM, IF it even does go there temporarily. They have more at stake than any of us and much more reason to want to see this succeed.
RSPI
mackwheaton mackwheaton 26 minutes ago
Thanks for bringing real numbers, and by themselves, those numbers would be concerning, especially if the losses were attached to what we would regard as ongoing revenues. But, in spite of their rush to describe themselves as a commercialized entity, they remain in late stages of development. Only n
POET
tw0122 tw0122 28 minutes ago
$ZPTA .67 + 15% perhaps .83-.92 zone gets hit. Low float AI quantum and algorithms. Has early volume
ZPTA
Dyno89 Dyno89 29 minutes ago
I specifically mentioned the timeframe of last few months moron. Where they stated they need funds to pay the auditing firm, but didn’t dilute any shares to do it.
RSPI
tw0122 tw0122 32 minutes ago
$15 ZAPP pump over cash in casino chips time
ZAPP
my2sense$ my2sense$ 33 minutes ago
Lets have a conference call. I would like to see a positive response to this. If interested, just say "yes"
SSOF
my2sense$ my2sense$ 35 minutes ago
WarMachine, you're a moron and have absolutely no idea what you are talking about ever!!!!
SSOF
lovethatgreen lovethatgreen 35 minutes ago
How many rabbits did they go through during 2.5 years.

I think they surpass the threshold of them needing to accept " less than non clinical data" jmo
RDGL
Tom turtles Tom turtles 35 minutes ago
Just put in a market order and it will immediately sell at .000001. What you been smoking ?
RNVA
dennisdave dennisdave 36 minutes ago
Not good, not good at all !!!
I take it you are not a SpongeBob SquarePants fan?
NWBO
sab63090 sab63090 36 minutes ago
Up early today, but will be gone today & Thursday for yet another "medical intervention"

Damn it, I'm old and I expect to be forgotten in 100 years or sooner.
AVXL
tw0122 tw0122 36 minutes ago
ZAPP $15.08 + 63%. Look as high as $26- $28 zone if pump continues. But first $16.80 $18 $19.80 $22
ZAPP

Your Recent History

EU
ALERS
Eurobio Scientific
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved